Cognition After OSA Treatment Among Native American People (CATNAP)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40+
SponsorWashington State University

About this trial

This research project will develop and implement a motivational interviewing and electronic messaging intervention to address obstructive sleep apnea (OSA), positive airway pressure (PAP) adherence, and risk of Alzheimer's disease and related dementias in American Indians. The project will work with American Indian Elders, aged 50 years and older, from three Northern Plains Reservations and surrounding communities. A total of 300 American Indian elders with a confirmed OSA diagnosis and prescribed PAP therapy will be randomized to receive usual care consisting of PAP therapy alone (control condition) or usual care plus the culturally informed CATNAP MI component (intervention condition).

Eligibility criteria

Qualifiers

Age 50 years and older

Self report American Indian or Alaskan Native

diagnosed with obstructive sleep apnea

prescribed PAP therapy and have a device

Disqualifiers

Living in a household with someone who is enrolled in the study

Already using PAP device at Medicaid recommended standards

Cognitive decline, unable to consent on their own

Trial design

Treatments tested in this trial

  • CATNAP MI

Treatment groups

140 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Washington State University

Lead sponsor

Missouri Breaks Industries Research, Inc.

Collaborator

University of Washington

Collaborator

University of Minnesota

Collaborator